Serum sex steroids, gonadotrophins and sex hormone-binding globulin in prostatic hyperplasia

Annals of Saudi Medicine

Volumn 28, Issue 3, 2008, Pages 174-178

  Ansari, Mohammad Abdul Jalil ^a,b   Begum, Dilruba ^b   Islam, Fakhrul ^c  

^a Section of Endocrinology   (Saudi Arabia)

^b BANGLADESH LIVESTOCK RESEARCH INSTITUTE   (Bangladesh)

^c Bangladesh International Medical College   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

GONADOTROPIN DERIVATIVE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ESTRADIOL BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; TESTOSTERONE BLOOD LEVEL;

EID: 50649092863     PISSN: 02564947     EISSN: 13199226     Source Type: Journal    
DOI: 10.5144/0256-4947.2008.174     Document Type: Article

References (34)

1. Horton R. Benign prostatic hypertrophy: A disorder of androgen metabolism. Am J Geriatrics 1984;32:320.
2. Wilson J. The pathogenesis of benign prostatic hyperplasia. Am J Med 1980;68:745.
3. Guess HA, Arrighi HM, Metter EJ et al. The cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia. Prostate 1990;17:24.
4. Guess HA. Epidemiology and natural history of benign prostatic hyperplasia. Uro clin North Am 1995;22:247-261.
5. Grayhack JT, Kozlowski JM, Lee Chung. The pathogenesis of benign prostatic hyperplasia: a proposed hypothesis and critical evaluation. J Urolo 1998;160: 2375-80.
6. Meigs JB, Mohr B, Barry MJ et al. Risk factors for clinical benign prostatic hyperplasia is a community based population of healthy aging men. J Clin Epidemiol 2001;54:935-44.
7. Vincenzo Mirone, Ferdinando Fusco,Paolo Verze et al. Androgens and benign prostatic hyperplasia. European Urology Suppl (5) 2006;410-17.
8. CarsonIII C, Ritmaster R. The role of dihydrotestosterone in benign prostatic hyperplasia. Urology 2003;61:2-7.
9. Stearns EI, Macdonell JA, Kauffman BJ et al. Decline of testicular function with age- hormonal and clinical correlates. Am J Med 1974;57:761.
10. Lynch AH. Benign prostatic hyperplasia- from bench to bedside (editorial) J urolo 1998;159:1978.
11. Vermeulen A, De Sy W. Androgens in patients with benign prostatic hyperplasia before and after prostatectomy. J Clin Endocrinol Metab 1976;43:1250-1254.
12. Bhasin S, Bagatell TJ, Bremner WJ et al. Issues in testosterone replacement in older men. J Endocrinol Metab 1998;83:3435-48.
13. Mass D, Jochen A, Lalande B. Age related changes in male gonadal function. Implications for therapy. Drugs aging 1997;11:45-60.
14. Barry MJ, Fowler FJ Jr, O'Leary MP et al. The American Urological Association Symptom Index for Benign prostatic Hyperplasia. J Urol 1992;148:1549-57.
15. Lagiou P, Mantzoros CS, Tzonou A et al. Serum steroids in relation to benign prostatic hyperplasia. Oncology 1997;54:497-501.
16. Hayward SW, Donjacour AA, Thompson AA, Cunha GR. Endocrinology of the prostate and benign prostatic hyperplasia (In) DeGroot JL, Jonson JL(editors) Endocrinology. Philadelphia, WB Saunders, 2001:2357-67.
17. Tan MO, Karabiyik I, Uygur MC et al. Serum concentration of sex hormones in men with severe lower urinary tract symptoms and benign prostatic hyperplasia. Int Urol Nephrol 2003;35(3):357-63.
18. Liu CC, Huang SP, Li WM et al. Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men. Urology 2007;70:677-80.
19. Rohrmann S, Nelson WG, Rifai N et al. Serum sex steroid hormones and lower urinary tract symptoms in Third National Health and Nutrition Examination Survey (NHANES III). Urology 2007;69:708-13.
20. Marberger M, Roehrborn CG, Marks LS et al. Relationship among serum testosterone, sexual function and response to treatment in men receiving dutasteride for benign prostatic hyperplasia. J Clin Endocrinol Metab 2006;91: 1323-28.
21. Hammond GL, Kontturi M, Vihko P, Vihko R. Serum steroids in normal males and patients with prostatic diseses. Clin Endocrinol (Oxf) 1978;9(2):113-21.
22. Grayhack JT, Kozlowski JM, Lee Chung. The pathogenesis of benign prostatic hyperplasia: a proposed hypothesis and critical evaluation. J Urolo 1998;160:2375-80.
23. Mc Connell JD. Prostate growth: new insights into hormonal regulation. Br J Urol 1995;76:5-10.
24. Weisher H, Kreig M. Benign prostatic hyperplasia - the outcome of age-induced alteration of androgen estrogen balance? Urologe 1997;36:3-9.
25. Harman SM, Tsitouras PD. Reproductive hormones in aging men- Measurement of sex steroids, basal leutinizing hormone, and leydig cell response to human chorionic gonadotrophins. J Clin Endocrinol Metab 1980;51:35-40.
26. Ferrini RL, Barrett-Conner E. Sex hormones and age: A cross sectional study of testosterone and estradiol and their bioavailable fractions in community dwelling men.Am J Epidemiol 1998;147:750-54.
27. Swerdloff RS, Wang C. Androgen deficiency and aging in men.West J Med 1993;159:579-85.
28. Tenover JL. Testosterone and the aging male. J andrology 1997; 8: 103-106.
29. Vermeulen A. Androgens in the aging males. J Clin Endocrinol Metab 1991;221-24.
30. Moroz EV, Verkhratsky NS, Hypophyseal-gonadal system during male aging. Arch-Gerontol Geriatr 1985;4(1):13-9.
31. Lewis JG, Ghanadian R, Chisholm GD Serum 5alpha-dihydrotestosterone and testosterone changes with age in man. Acta Endocrinol (Copenh) 1976;82(2):444-8.
32. Ferrini RL, Barrett-Connor E. Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol 1998;15:147:750-4.
33. Simon D, Preziosi P, Barrett-Connor E et al. The influence of aging on plasma sex hormones in men: the Telecom Study. Am J Epidemiol 1992;135:783-91.
34. Orwoll E, Lambert LC, Marshal LM et al. Testosterone and estradiol among older men. J Clin Endocrinol Metab 2006;91:1223-25.